Petra B. Musholt

Different mRNA and Protein Expression of Matrix Metalloproteinases 2 and 9 and Tissue Inhibitor of Metalloproteinases 1 in Benign and Malignant Prostate Tissue

Ralf Lichtinghagen, Petra B. Musholt, Michael Lein et al. · European Urology · 2002 · 138 citations

Urology, Metalloprotein, Tissue Inhibitor +9

Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma

Thomas J. Musholt, Petra B. Musholt, Nawid Khaladj et al. · Surgery · 2000 · 108 citations

Thyroid Disease, Pathology, Prognostic Significance +4

Familial Papillary Thyroid Carcinoma: Genetics, Criteria for Diagnosis, Clinical Features, and Surgical Treatment

Thomas J. Musholt, Petra B. Musholt, T. Petrich et al. · World Journal of Surgery · 2000 · 107 citations

Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts

Naeimeh Atabaki‐Pasdar, Mattias Ohlsson, Ana Viñuela et al. · PLoS Medicine · 2020 · 88 citations · Full text

Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: A clinical and molecular study

Thomas J. Musholt, Petra B. Musholt, Farrokh Dehdashti et al. · Surgery · 1997 · 86 citations

Neuro-oncology, Thyroid Disease, Neuroendocrine Disorder +7